Cancer chromosomes in crisis
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The benign-to-malignant transition in human breast cancer is associated with a marked increase in chromosomal aberrations. A new study suggests that telomere dysfunction and its associated bridge-fusion-breakage cycles may drive this episodic instability, thereby providing aspiring cancer cells with the multiple genetic aberrations needed to achieve a fully malignant state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These fusions are the basis of genomic instability associated with telomere dysfunction as they lead to anaphase bridging, subsequent breakage and that requires further repair. Repetition of this fusion-bridge-breakage cycle leads to aneuploidy, further fusions and depending on how such DNA damage is resolved, it has been hypothesized that loss of heterozygosity or gene amplification could result”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [21]
In the citing paper
“The chromosomal structure of three chromosomes fused centromere to telomere is typical of a breakage-fusion-bridge cycle that can lead to gene amplifications or translocations and is associated with tumorigenesis (DePinho and Polyak, 2004).”
From Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression (2011) · cites this paper as DePinho and Polyak, 2004
Citations
Cites
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Self-citationChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Self-citationDePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
Self-citationGene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
From polyploidy to aneuploidy, genome instability and cancer
Storchova, Z., & Pellman, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1276 · Cited by 810
Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527
Self-citationTelomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia
van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J. A., Hicks, J. L., Wilentz, R. E., Goggins, M. G., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64432-x · Cited by 363
In situ analyses of genome instability in breast cancer
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., et al. (2004) · Nature Genetics · doi:10.1038/ng1409 · Cited by 361
Molecular markers in ductal carcinoma in situ of the breast.
PORTER, D. A., Lahti‐Domenici, J., Keshaviah, A. P., Bae, Y. K., Argani, P., Marks, J. R., Richardson, A. L., Cooper, A. G., Strausberg, R. L., Riggins, G. J., et al. (2003) · PubMed · Cited by 265
Research works printed but not linked: 1
- Porter, D. et al. Mol. Cancer Res. 1, 362–375 (2003).
Cited by
Punctuated copy number evolution and clonal stasis in triple-negative breast cancer
Gao, R., Davis, A., McDonald, T. O., Sei, E., Shi, X., Wang, Y., Tsai, P.-C., Casasent, A., Waters, J., Zhang, H., et al. (2016) · Nature Genetics · doi:10.1038/ng.3641 · Cited by 523
Dissecting the Heterogeneity of Triple-Negative Breast Cancer
Metzger-Filho, O., Tutt, A., de Azambuja, E., Saini, K. S., Viale, G., Loi, S., Bradbury, I., Bliss, J. M., Azim, H. A., Ellis, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2010 · Cited by 465
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
“Repetition of this breakage–fusion–bridge cycle leads to aneuploidy and further fusions and, depending on how such DNA damage is resolved, it has been hypothesized that loss of heterozygosity or gene amplification could result in tumorigenesi”
BackgroundTumor evolution: Linear, branching, neutral or punctuated?
Davis, A., Gao, R., & Navin, N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.01.003 · Cited by 352
Novel patterns of genome rearrangement and their association with survival in breast cancer
Hicks, J., Krasnitz, A., Lakshmi, B., Navin, N. E., Riggs, M., Leibu, E., Esposito, D., Alexander, J., Troge, J., Grubor, V., et al. (2006) · Genome Research · doi:10.1101/gr.5460106 · Cited by 319
“…physiological context of the cancer within the host, such as the proportion of normal stroma and the degree of inflammatory response, or the degree of hypoxia, as well as methods used for extraction and preservation of sample, are all potentially useful but confounding factors (Edén et al. 2004).”
Method
Metadata
- Authors
- DePinho, R. A., & Polyak, K.
- Affiliations
- Harvard University (US)
- ORCID
- DePinho, Ronald A.
- Venue
- Nature Genetics
- Published
- 2004-09-01
- Volume
- 36
- Issue
- 9
- Pages
- 932-934
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2053271633
- Cited by
- 91
- References
- 11
- Citations by year
- 2025: 3 · 2023: 2 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 3 · 2013: 6 · 2012: 6
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- breast cancer, chromosomal instability, telomere dysfunction, chromosomal abnormalities, tumor progression
- MeSH terms
- Aneuploidy, Breast Neoplasms, Chromosome Aberrations, Female, Humans, Models, Biological, Neoplasms, Telomere, Disease Progression, Chromosomal Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.